Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant.
Müller V, Polivka L, Valyi-Nagy I, Nagy A, Szekanecz Z, Bogos K, Vago H, Kamondi A, Fekete F, Szlavik J, Elek J, Surján G, Surján O, Nagy P, Schaff Z, Müller C, Kiss Z, Kásler M. Müller V, et al. Among authors: szekanecz z. Vaccines (Basel). 2022 Jun 21;10(7):986. doi: 10.3390/vaccines10070986. Vaccines (Basel). 2022. PMID: 35891151 Free PMC article.
Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study.
Sütő G, Molnár GA, Rokszin G, Fábián I, Kiss Z, Szekanecz Z, Poór G, Jermendy G, Kempler P, Wittmann I. Sütő G, et al. Among authors: szekanecz z. BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001765. doi: 10.1136/bmjdrc-2020-001765. BMJ Open Diabetes Res Care. 2021. PMID: 33472796 Free PMC article.
[Antiviral and anti-inflammatory therapies in COVID-19].
Szekanecz Z, Bogos K, Constantin T, Fülesdi B, Müller V, Rákóczi É, Várkonyi I, Vályi-Nagy I. Szekanecz Z, et al. Orv Hetil. 2021 Apr 10;162(17):643-651. doi: 10.1556/650.2021.32230. Orv Hetil. 2021. PMID: 33838023 Hungarian.
[Post-acute COVID-19 syndrome].
Szekanecz Z, Vályi-Nagy I. Szekanecz Z, et al. Orv Hetil. 2021 Jul 4;162(27):1067-1078. doi: 10.1556/650.2021.32282. Orv Hetil. 2021. PMID: 34224394 Review. Hungarian.
Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study.
Rokszin G, Kiss Z, Sütő G, Kempler P, Jermendy G, Fábián I, Szekanecz Z, Poór G, Wittmann I, Molnár GA. Rokszin G, et al. Among authors: szekanecz z. Front Oncol. 2021 Oct 28;11:725465. doi: 10.3389/fonc.2021.725465. eCollection 2021. Front Oncol. 2021. PMID: 34778040 Free PMC article.
Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study).
Kiss Z, Wittmann I, Polivka L, Surján G, Surján O, Barcza Z, Molnár GA, Nagy D, Müller V, Bogos K, Nagy P, Kenessey I, Wéber A, Pálosi M, Szlávik J, Schaff Z, Szekanecz Z, Müller C, Kásler M, Vokó Z. Kiss Z, et al. Among authors: szekanecz z. Front Immunol. 2022 Jun 23;13:905585. doi: 10.3389/fimmu.2022.905585. eCollection 2022. Front Immunol. 2022. PMID: 35812442 Free PMC article.
Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study).
Vokó Z, Kiss Z, Surján G, Surján O, Barcza Z, Wittmann I, Molnár GA, Nagy D, Müller V, Bogos K, Nagy P, Kenessey I, Wéber A, Polivka L, Pálosi M, Szlávik J, Rokszin G, Müller C, Szekanecz Z, Kásler M. Vokó Z, et al. Among authors: szekanecz z. Front Immunol. 2022 Jul 22;13:919408. doi: 10.3389/fimmu.2022.919408. eCollection 2022. Front Immunol. 2022. PMID: 35935993 Free PMC article.
373 results